John R. Wunderlich

32.7k citations

121 papers · 21.1k indexed · 13 hit papers · h-index 54

Impact in

Immunology top 0.02%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 0.02%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 89
- Immunotherapy and Immune Responses 68
- Immune Cell Function and Interaction 23
- T-cell and B-cell Immunology 18
Oncology 65
- CAR-T cell therapy research 51
- Cancer Immunotherapy and Biomarkers 22

Co-authors: Steven A. Rosenberg Mark E. Dudley Paul F. Robbins Donald E. White James Chih‐Hsin Yang Richard M. Sherry Nicholas P. Restifo Udai S. Kammula
Journals: The Journal of Immunology (21 papers)Clinical Cancer Research (16 papers)Journal of Immunotherapy (15 papers)Journal of Clinical Oncology (7 papers)Transplantation (5 papers)
Partner nations: United States Malaysia Australia

In The Last Decade

John R. Wunderlich

121 papers receiving 20.5k citations

Hit Papers

13 papers align trajectories log scale

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients 2016 · 597 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Nature Medicine
2015 Journal of Clinical Oncology
2015 Science
2014 Journal of Clinical Investigation
2014 Clinical Cancer Research
2014 Science
2011 Clinical Cancer Research
2009 Blood
2008 Journal of Clinical Oncology
2006 Clinical Cancer Research
2006 Science
2003 Journal of Immunotherapy
2002 Science

Peers

Countries citing papers authored by John R. Wunderlich

Since Specialization

Citations

This map shows the geographic impact of John R. Wunderlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Wunderlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Wunderlich more than expected).

Fields of papers citing papers by John R. Wunderlich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Wunderlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Wunderlich. The network helps show where John R. Wunderlich may publish in the future.

Co-authors

The 25 scholars most cited alongside John R. Wunderlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John R. Wunderlich Line = papers co-authored together John R. Wunderlich links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers Clinical Cancer Research ·Drew C. Deniger, Anna Pasetto, Paul F. Robbins, Jared J. Gartner, Todd D. Prickett, Biman C. Paria, Parisa Malekzadeh, Lee Jia, Rami Yossef, Michelle M. Langhan, John R. Wunderlich, David N. Danforth, Robert Somerville, Steven A. Rosenberg	2018	110
2	A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers Clinical Cancer Research ·Sanja Stevanović, Sarah R. Helman, John R. Wunderlich, Michelle M. Langhan, Stacey L. Doran, Mei Li M. Kwong, Robert Somerville, Christopher A. Klebanoff, Udai S. Kammula, Richard M. Sherry, James Chih‐Hsin Yang, Steven A. Rosenberg, Christian S. Hinrichs	2018	204
3	Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer Clinical Cancer Research ·Yasmine Assadipour, Nikolaos Zacharakis, Jessica S. Crystal, Todd D. Prickett, Jared J. Gartner, Robert Somerville, Hui Xu, Mary A. Black, Li Jia, Harshini Chinnasamy, Isaac Kriley, Lily Lu, John R. Wunderlich, Zhili Zheng, Yong‐Chen Lu, Paul F. Robbins, Steven A. Rosenberg, Stephanie L. Goff, Steven A. Feldman	2017	28
4	Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells Journal of Clinical Oncology ·Sanja Stevanović, Lindsey M. Draper, Michelle M. Langhan, P.S. MORTIMER, Mei Li M. Kwong, John R. Wunderlich, Mark E. Dudley, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Nicholas P. Restifo, Steven A. Rosenberg, Christian S. Hinrichs Hit paper breakdown →	2015	506
5	Identification of an Immunogenic Subset of Metastatic Uveal Melanoma Clinical Cancer Research ·Luke D. Rothermel, Arvind Sabesan, Daniel J. Stephens, Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Robert Somerville, John R. Wunderlich, Chyi‐Chia Richard Lee, Liqiang Xi, Trinh Pham, Mark Raffeld, Parthav Jailwala, E D Standop, Udai S. Kammula	2015	64
6	Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans Clinical Cancer Research ·Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula	2014	39
7	Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration Clinical Cancer Research ·Edmund K. Bartlett, Patricia Fetsch, Armando Filie, Andrea Abati, Seth M. Steinberg, John R. Wunderlich, Donald E. White, Daniel J. Stephens, Francesco M. Marincola, Steven A. Rosenberg, Udai S. Kammula	2014	21
8	A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response Clinical Cancer Research ·Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Jessica S. Crystal, Richard A. Morgan, Steven A. Feldman, James Chih‐Hsin Yang, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi‐Chia Richard Lee, Yong F. Li, Mona El‐Gamil, Steven A. Rosenberg Hit paper breakdown →	2014	585
9	Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy Clinical Cancer Research ·Simon Turcotte, Alena Gros, Eric Tran, Chyi‐Chia Richard Lee, John R. Wunderlich, Paul F. Robbins, Steven A. Rosenberg	2013	45
10	Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy Clinical Cancer Research ·Rachel E. Beard, Daniel Abate‐Daga, Shannon F. Rosati, Zhili Zheng, John R. Wunderlich, Steven A. Rosenberg, Richard A. Morgan	2013	48
11	Longitudinal Study of Recurrent Metastatic Melanoma Cell Lines Underscores the Individuality of Cancer Biology Journal of Investigative Dermatology ·Zoltán Pós, Tara Spivey, Hui Liu, Michele Sommariva, Jinguo Chen, John R. Wunderlich, Giulia Parisi, Sara Tomei, M. J. Park, David F. Stroncek, Joel A. Malek, Paul F. Robbins, Licia Rivoltini, Michele Maio, Lotfi Chouchane, Ena Wang, Francesco M. Marincola	2013	3
12	Myeloid Cells Obtained from the Blood but Not from the Tumor Can Suppress T-cell Proliferation in Patients with Melanoma Clinical Cancer Research ·Alena Gros, Simon Turcotte, John R. Wunderlich, Mojgan Ahmadzadeh, Mark E. Dudley, Steven A. Rosenberg	2012	73
13	Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy Clinical Cancer Research ·Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurençot, Seth M. Steinberg, Donald E. White, Mark E. Dudley Hit paper breakdown →	2011	1603
14	Assessment of Ovarian Function After Preparative Chemotherapy and Total Body Radiation for Adoptive Cell Therapy Journal of Immunotherapy ·Russell C. Langan, Peter A. Prieto, Richard M. Sherry, Daniel Zlott, John R. Wunderlich, György Csákó, Rene Costello, Donald E. White, Steven A. Rosenberg, James C. Yang	2011	16
15	CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma Clinical Cancer Research ·Mark E. Dudley, Colin Gross, Michelle M. Langhan, Marcos Ríos García, Richard M. Sherry, James C. Yang, Giao Q. Phan, Udai S. Kammula, Marybeth S. Hughes, Deborah E. Citrin, Nicholas P. Restifo, John R. Wunderlich, Peter A. Prieto, Jenny J. Hong, Russell C. Langan, Daniel Zlott, Kathleen E. Morton, Donald E. White, Carolyn M. Laurençot, Steven A. Rosenberg	2010	245
16	Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens Journal of Clinical Oncology ·Mark E. Dudley, James Chih‐Hsin Yang, Richard M. Sherry, Marybeth S. Hughes, Richard E. Royal, Udai S. Kammula, Paul F. Robbins, Fui Fadla, Deborah E. Citrin, Susan F. Leitman, John R. Wunderlich, Nicholas P. Restifo, Wanda Leonata, Jingyu Li, Franz O. Smith, Jacob A. Klapper, Kathleen E. Morton, Carolyn M. Laurençot, Donald E. White, Steven A. Rosenberg Hit paper breakdown →	2008	1017
17	Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes Science ·Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg Hit paper breakdown →	2006	1961
18	Cutting Edge: Persistence of Transferred Lymphocyte Clonotypes Correlates with Cancer Regression in Patients Receiving Cell Transfer Therapy The Journal of Immunology ·Paul F. Robbins, Mark E. Dudley, John R. Wunderlich, Mona El‐Gamil, Yong F. Li, Juhua Zhou, Jianping Huang, Daniel J. Powell, Steven A. Rosenberg	2004	375
19	High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens The Journal of Immunology ·Richard A. Morgan, Mark E. Dudley, Yik Y. L. Yu, Zhili Zheng, Paul F. Robbins, Marc R. Theoret, John R. Wunderlich, Marybeth S. Hughes, Nicholas P. Restifo, Steven A. Rosenberg	2003	175
20	Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy International Journal of Clinical & Laboratory Research ·John R. Wunderlich, Delia Mezzanzanica, María Garrido, Ronghui Geng, Peter E. Daddona, Sarah M. Andrew, Vincent R. Zurawski, Silvana Canevari, Maria I. Colnaghi, David M. Segal	1992	4

About John R. Wunderlich

John R. Wunderlich is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Genetics, having authored 121 papers that have together received 21.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (68 papers), CAR-T cell therapy research (51 papers), Immune Cell Function and Interaction (23 papers), Monoclonal and Polyclonal Antibodies Research (22 papers), Cancer Immunotherapy and Biomarkers (22 papers), T-cell and B-cell Immunology (18 papers), Virus-based gene therapy research (17 papers) and RNA Interference and Gene Delivery (10 papers). The work is most often cited by research in Immunology (14.8k citations), Oncology (15.8k citations), Genetics (3.4k citations), Molecular Biology (4.8k citations) and Biotechnology (571 citations). John R. Wunderlich has collaborated with scholars based in United States, Malaysia and Australia. Frequent co-authors include Steven A. Rosenberg, Mark E. Dudley, Paul F. Robbins, Donald E. White, James Chih‐Hsin Yang, Richard M. Sherry, Nicholas P. Restifo, Udai S. Kammula, Marybeth S. Hughes and Linda Rogers-Freezer. Their work appears in journals such as The Journal of Immunology, Clinical Cancer Research, Journal of Immunotherapy, Journal of Clinical Oncology and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact